Oxycodone Teva (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodone Teva, is an opioid analgesic presented as a solid oral dosage form for oral use. It is prescribed for the management of moderate to severe pain in adult patients. GNH USA supplies Oxycodone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxycodone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxycodone Teva is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: Provides effective relief of pain following surgical procedures. - Cancer‑related pain: Helps manage persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: Reduces intensity of long‑term pain when other analgesics are insufficient.

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects: - Nausea: Feeling of stomach upset or urge to vomit. - Constipation: Reduced bowel movements and hard stools. - Drowsiness: Increased sleepiness or fatigue. - Dry mouth: Reduced salivation leading to a parched feeling. - Dizziness: Light‑headed sensation, especially when standing quickly. - Itching: Mild skin irritation or pruritus.

Serious or Rare Side Effects: - Respiratory depression: Slowed or shallow breathing that can be life‑threatening. - Severe hypotension: Markedly low blood pressure causing faintness. - Seizures: Uncontrolled electrical activity in the brain. - Allergic reactions: Rash, swelling, or anaphylaxis. - Dependence and withdrawal: Physical and psychological reliance with withdrawal symptoms on abrupt discontinuation.

When prescribing oxycodone, clinicians should assess patient history and monitor for adverse outcomes.

- Assess risk of addiction: Evaluate personal or family history of substance misuse. - Monitor respiratory function: Observe for signs of slowed breathing, especially after dose changes. - Adjust for renal/hepatic impairment: Dose may need modification in patients with liver or kidney disease. - Avoid concurrent CNS depressants: Limit use with alcohol, benzodiazepines, or other sedatives. - Educate on constipation management: Recommend diet, fluids, and laxatives as needed. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Oxycodone may interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined with other opioids: Increases risk of respiratory depression and profound sedation. - Concurrent use with benzodiazepines: Heightens potential for severe respiratory depression. - MAO inhibitors: May precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., antihistamines, muscle relaxants): May enhance drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Can raise oxycodone plasma levels. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): May reduce analgesic effect.